| Metric | Value (₹ Cr) | Q2 FY26 | Q3 FY25 |
|---|---|---|---|
| Revenue | 459.85 | 6.8% | 2.8% |
| Total Income | 461.91 | 6.4% | 2.5% |
| Expenditure | 440.54 | 5.2% | 0.4% |
| PBT | 13.49 | 123.7% | 59.3% |
| Net Profit | 8.25 | 119.8% | 43.2% |
| OPM | 7.65% | 15.68pp | 13.53pp |
| NPM | 1.79% | 11.37pp | 0.51pp |
| EPS | 1.61 | 80.2% | 22.9% |
Godavari Biorefineries Ltd Reports Q3 & 9M FY26 Results: Operating Leverage Drives Profitability and Improved Margins
13 Feb 2026 · 13 Feb, 7:52 pm
Summary
Godavari Biorefineries Ltd, one of the largest producers of ethanol and a pioneer in manufacturing bio-based specialty chemicals in India, announced its Financial Results for the quarter and nine months ended on Dec 31, 2025. The company reported a significant increase in profitability, driven by operating leverage and disciplined execution. EBITDA grew approximately 14% year-on-year to 45.1 crore, while PBT before exceptional items surged 152% year-on-year to 21.4 crore. The Bio-based Chemicals segment continued to support profitability, with specialty chemicals contributing 62% of the basket in 9M FY26. The company is also focusing on high-margin segments, sustainability, green chemistry, and next-generation energy solutions.
Key Highlights
- 1
Q3 FY26 Financial Performance Snapshot: Total Income - 21.4 Cr, EBITDA - 461.9 Cr, PBT - 45.1 Cr
- 2
Key Financial Highlights (Consolidated): Y-o-Y PBT growth of 152.2%, PBT Margin of 4%
- 3
Segment Highlights: EBITDA for Godavari Biorefineries Ltd. segment is 460 Crores
- 4
Revenue from Operations: 460 Crores for Q3 FY26
- 5
Bio-Based Chemicals segment contributing 62% of the basket in 9M FY26
- 6
Grant of a U.S. patent for a novel anti-cancer molecule targeting triple-negative breast cancer
- 7
DME-to-CO2 technology initiative is progressing well
- 8
Collaboration with Synthomer to develop bio-based alternatives to fossil-based monomers
- 9
Jivana brand crossed the 100 crore revenue milestone in the first nine months of FY26
- 10
Fungible grain-based ethanol capacity to be commissioned in Q1 FY27
Management Comments
Shri Samir Somaiya
CMD
Q3 FY26 marked a quarter of significantly improved profitability, driven by operating leverage and disciplined execution. EBITDA grew approximately 14% year-on-year to 45.1 crore, while PBT before exceptional items surged 152% year-on-year to 21.4 crore. Our margins also expanded meaningfully as we focus more on high-margin segments, reinforcing the company’s strategic direction.
Informational and educational content only. Not investment advice.